| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/30/2008 | US7470712 Amino-benzazoles as P2Y1 receptor inhibitors |
| 12/30/2008 | US7470711 Piperidinyl substituted cyclohexane-1,4-diamines |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470709 Benzimidazole quinolinones and uses thereof |
| 12/30/2008 | US7470708 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 12/30/2008 | US7470707 Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparation |
| 12/30/2008 | US7470706 Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
| 12/30/2008 | US7470705 e.g. Cis-4-[acety1-(3,5-bis-trifluoromethyl-benzyl)-amino]-2-ethyl-6-methoxy-3,4-dihydro-2H- [1,5]naphthyridine-1-carboxylic acid isopropyl ester; cholesterol ester transfer protein (CETP) inhibitors; increasing plasma HDL- cholesterol, decreasing plasma LDL- cholesterol; atherosclerosis |
| 12/30/2008 | US7470704 Benzonaphthyridines |
| 12/30/2008 | US7470703 Yohimbine derivatives and use thereof |
| 12/30/2008 | US7470702 Benzimidazoles |
| 12/30/2008 | US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/30/2008 | US7470698 Adenosine A3 receptor modulators |
| 12/30/2008 | US7470697 E.g.,1-(2-(dimethylamino)ethyl)-3-(4-fluorophenyl)-1-(5-(2,3,4,5-tetrahydro-2,4-dioxo-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidin-6-yl)pyridin-2-yl)urea; antidiarrhea and -ischemic agents; antidiabetic agents/insulin-resistance; asthma; antiallergens; obesity; autoimmune diseases; reperfusion injuries |
| 12/30/2008 | US7470696 Tyrosine kinase inhibitors |
| 12/30/2008 | US7470695 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 12/30/2008 | US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 12/30/2008 | US7470693 Oxalamide derivatives as kinase inhibitors |
| 12/30/2008 | US7470692 e.g. 4-[2-(5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-1-methyl-1H-indole-7-carbonyl]-piperazine-1-carboxylic acid ethyl ester; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma |
| 12/30/2008 | US7470691 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 12/30/2008 | US7470690 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder |
| 12/30/2008 | US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent |
| 12/30/2008 | US7470688 Phthalazinone derivatives |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres |
| 12/30/2008 | US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis |
| 12/30/2008 | US7470684 Spiropiperidine derivatives as NK3 antagonists |
| 12/30/2008 | US7470683 Tetracyclic compounds |
| 12/30/2008 | US7470682 Rapamycin analogues and the uses thereof in the treatment of neurological disorders |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/30/2008 | US7470680 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (9-benzyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(R)-cyclohepta[e]inden-7-yl)-amide; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, menopause, asthma |
| 12/30/2008 | US7470679 Constrained compounds as CGRP-receptor antagonists |
| 12/30/2008 | US7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 12/30/2008 | US7470677 Oxidant scavengers |
| 12/30/2008 | US7470674 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 12/30/2008 | US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents |
| 12/30/2008 | US7470672 doxorubicin orotate for reduce the side effect of antitumor agent in noncancerous tissues; reduce the toxicity of anthracyclines, doxorubicin and daunorubicin anticancer drugs |
| 12/30/2008 | US7470671 Thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics |
| 12/30/2008 | US7470660 reducing, prevention, reverse cholesterol transportation; supplying apolipoprotein |
| 12/30/2008 | US7470659 Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
| 12/30/2008 | US7470527 Preparation of microbial oil |
| 12/30/2008 | US7470509 Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer |
| 12/30/2008 | US7470506 Fitness assay and associated methods |
| 12/30/2008 | US7470437 Utilizing nanocrystalline silver metal, alloy or compound for mucosal, serosal, respiratory, circulatory and/or musculo-skeletal conditions |
| 12/30/2008 | US7470436 Water-soluble composition containing coenzyme Q10 |
| 12/30/2008 | US7470435 Pellets containing binder |
| 12/30/2008 | US7470433 Topical mixtures of estrogens or progesterones, and drug delivery vehicles comprising alcohols, alcohols-2+ or polyoxyalylene glycols, and permeation enhancer comprising a monoalkyl ether of diethylene glycol |
| 12/30/2008 | US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization |
| 12/30/2008 | US7470422 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 12/30/2008 | US7470421 Delivery of diazepam through an inhalation route |
| 12/30/2008 | US7470397 Disintegratable films for diagnostic devices |
| 12/30/2008 | US7470266 Fluid medication delivery device |
| 12/30/2008 | CA2512315C Biodegradable ocular implant |
| 12/30/2008 | CA2495527C New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 12/30/2008 | CA2446903C Imidazo ¬1,5-a| pyrimido ¬5,4-d| benzazepine derivatives as gaba a receptor modulators |
| 12/30/2008 | CA2441771C Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i |
| 12/30/2008 | CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2412452C Process for the preparation of substituted octanoyl amides |
| 12/30/2008 | CA2400237C Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 12/30/2008 | CA2395652C New derivatives of benzo[b]pyrano[3,2-h]acridin-7-one, process for preparing them, and pharmaceutical compounds containing them |
| 12/30/2008 | CA2391497C Use of 5ht3 agonists for relaxing the fundus |
| 12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
| 12/30/2008 | CA2387873C Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 12/30/2008 | CA2381354C Utilisation de la cyamemazine dans le traitement du sevrage brutal aux benzodiazepines |
| 12/30/2008 | CA2364258C 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/30/2008 | CA2353048C Pharmaceutical composition useful in the prevention or treatment of peptic ulcers |
| 12/30/2008 | CA2352676C Composition and method for treatment of symptoms associated with insufficient estrogen production |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2349195C New manufacturing process |
| 12/30/2008 | CA2343893C Iontophoretic drug delivery electrodes |
| 12/30/2008 | CA2327398C Methods and compositions for stabilizing acetylcholine compositions |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/30/2008 | CA2305139C Disinfectant and method of making |
| 12/30/2008 | CA2304557C Polyamine transport inhibitors |
| 12/30/2008 | CA2299423C Taste-masked pharmaceutical composition |
| 12/30/2008 | CA2298059C Nucleotide analog composition and synthesis method |
| 12/30/2008 | CA2294243C Novel cyanoaziridines for treating cancer |
| 12/30/2008 | CA2288482C Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis |
| 12/30/2008 | CA2285389C Use of cytoskeletal inhibitors for the prevention of restenosis |
| 12/30/2008 | CA2282378C Pharmaceutical composition |
| 12/30/2008 | CA2281251C Sterol esters in tableted solid dosage forms |
| 12/30/2008 | CA2253207C Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
| 12/30/2008 | CA2250295C Water soluble paclitaxel prodrugs |
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/30/2008 | CA2245545C Vaccines against varicella zoster virus gene 63 product |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/30/2008 | CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 12/30/2008 | CA2215190C Aryl-ester phosphoramidate derivatives of nucleosides |
| 12/30/2008 | CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 12/30/2008 | CA2189351C Narcotic containing aerosol formulation |
| 12/30/2008 | CA2186364C Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 12/30/2008 | CA2143045C Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and process for their preparation |
| 12/30/2008 | CA2132349C Chimeric receptor genes and cells transformed therewith |
| 12/29/2008 | CA2610820A1 Method for maintaining physiological ph levels during intensive physical exercise |
| 12/25/2008 | US20080319551 Thioester-ester-amide copolymers |
| 12/25/2008 | US20080319222 Crystal forms of N- (trans-4-isopropylctyclohexylcarbonyl) -D-phenylalanine |